Top Tech Companies (65)
Symmetron is an established boutique health economics and health outcomes research consultancy that helps companies realise and communicate the value of their drugs and devices. Our mission is to increase access to healthcare that saves lives and improves quality of life for people around the world. We provide a full range of services for clients seeking market access and reimbursement...
TIME FOR TRANSFORMATION The real world is now a multi-dimensional universe of decision makers, evidence needs and healthcare systems requiring a connected, systematic and dynamic approach to medical and evidence planning, data dissemination, stakeholder engagement and education. The opportunity extends beyond traditional medical agency services to meet the growing and diversifying needs of medical affairs and finding integrated solutions in a fragmented...
DentalMonitoring, powered by AI, is the orthodontic industry’s only FDA-approved and EU-MDR-Certified remote monitoring solution. The platform is revolutionizing the orthodontic experience for patients, parents, and practitioners. Clinicians use DentalMonitoring to see every patient weekly and schedule appointments based on how their patient’s biology responds to treatment. ScanAssist guides patients through the scanning experience and ensures high-quality images with meaningful...
Simple Pharma is the best home for proven pharma products. We provide integrated, digitally enabled, end to end operations, distribution, and compliance services to pharma companies. We’re passionate about simplifying the complex world of pharma operations to enable better access to medicines on a global scale. Simple Pharma is re-thinking the traditional sales-led model of the pharma industry by focusing...
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders
